Turkish healthcare company wants to add fertility management products to their portfolio.


A Turkish company is interested in adding fertility management products to their range through distribution agreements. They would like to meet with companies which haven't been represented in the Turkish market.

The Turkish company:

- is based in Ankara
- mainly focuses on in-vitro diagnostic products
- was established in 2001
- concentrates on cardiology and diabetics as its core activities
- has represented European, South Korea and USA brands

Register your interest for more information from our team in Turkey.

Essential information

Sectors:

Biotechnology & Pharmaceuticals and Healthcare & Medical

Opportunity type:

Private Sector

Expiry date:

30 August 2017

Applications received:

2

Value of contract:

Less than £100k

Apply for this opportunity